key: cord-0843030-44efbz6a
authors: Wahidi, Momen M.; Lamb, Carla; Murgu, Septimiu; Musani, Ali; Shojaee, Samira; Sachdeva, Ashutosh; Maldonado, Fabien; Mahmood, Kamran; Kinsey, Matthew; Sethi, Sonali; Mahajan, Amit; Majid, Adnan; Keyes, Colleen; Alraiyes, Abdul H.; Sung, Arthur; Hsia, David; Eapen, George
title: American Association for Bronchology and Interventional Pulmonology (AABIP) Statement on the Use of Bronchoscopy and Respiratory Specimen Collection in Patients With Suspected or Confirmed COVID-19 Infection
date: 2020-03-18
journal: J Bronchology Interv Pulmonol
DOI: 10.1097/lbr.0000000000000681
sha: 3f57d32180d7ef7298cba9989b3288796684324e
doc_id: 843030
cord_uid: 44efbz6a

nan

Pulmonology (AABIP) is issuing this statement on the safe and effective use of bronchoscopy in patients with suspected or confirmed COVID-19 infection. The main purpose of this statement is to ensure the safety of our patients, health care team and community at large.

We are releasing these urgent recommendations to guide clinicians around the world with the understanding that new information may subsequently modify or impact these current recommendations. We will strive to update this statement as needed in a timely fashion. This document is based on the latest Centers for Disease Control (CDC) recommendations March 9, 2020 and expert consensus of the AABIP COVID-19 Task Force.

General Recommendations for collection of respiratory specimen collection for suspected COVID-19: [1] [2] [3] [4] Collection of upper respiratory samples via nasopharyngeal and oropharyngeal swabs is the primary and preferred method for diagnosis. Respiratory specimen collection is recommended in suspected COVID-19 regardless of time of onset of symptoms. Induced sputum collection is NOT recommended.

Because it is an aerosol generating procedure that poses substantial risk to patients and staff, bronchoscopy should have an extremely limited role in the diagnosis of COVID-19 and only be considered in intubated patients if upper respiratory samples are negative and other diagnosis is considered that would significantly change clinical management. Alternative respiratory specimen collection in the intubated patient can include tracheal aspirates and nonbronchoscopic alveolar lavage. If bronchoscopy is being performed for COVID-19 sample collection, a minimum of 2-3 mL of specimen into a sterile, leak proof container for specimen collection is recommended. 4 Only essential personnel should be present when performing any specimen collection. Alert laboratory personnel regarding COVID-19 specimen processing and testing.

Constellation of fever, respiratory symptoms, and radio-graphic evidence of ground glass opacities and pneumonitis should raise clinical suspicion of COVID-19. 5 Information contained in this document will be updated regularly as new information becomes available. For the latest version, please visit https:// aabronchology.org/.

Available at: www

Respiratory support for patients with COVID-19 infection

Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. China CDC Weekly

World Health Organization Laboratory testing for 2019 novel Coronavirus (2019-nCov) in suspected human cases. Interim Guidance

Correlation of chest CT and RT-PCR testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases online RSNA.org

Essentials for radiologists on COVID-19: an update online RSNA.org